Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

FFA can be mistaken for rosacea, requiring specific treatment for accurate diagnosis and management.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Two patients with a rare scalp fungus in Poland were successfully treated with griseofulvin and ciclopirox.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Some cancer treatments can cause permanent hair loss.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

There are various treatment options for frontal fibrosing alopecia.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Scalp cooling can help prevent hair loss from chemotherapy without raising cancer spread risk.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.